Pfizer and Allergan in Big Inversion Deal

Pfizer Inc. and Allergan plc have agreed to merge in a huge – as in $160 billion – deal, the New York Times reports. That not only makes it one of the biggest mergers ever in the health care industry but the largest so-called inversion. Because Dublin-based Allergan would technically be the buyer, the combined company would escape many of America’s high taxes.